Depression in Parkinson's disease. Assessment and treatment

被引:7
|
作者
Brand, S.
Dodel, R.
Hautzinger, M.
Grunder, G.
Althaus, A.
Schneider, F.
机构
[1] Rhein Westfal TH Aachen, Klin Psychiat & Psychotherapie, Univ Klinikum Aachen, D-52074 Aachen, Germany
[2] Univ Marburg, Neurol Klin, Marburg, Germany
[3] Univ Tubingen, Abt Klin Psychol & Entwicklungspsychol, Arbeitseinheit Klin Psychol & Psychotherapie, Tubingen, Germany
来源
NERVENARZT | 2007年 / 78卷 / 06期
关键词
assessment; depression; mood disorders; Parkinson's disease; treatment;
D O I
10.1007/s00115-007-2292-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
With a prevalence of 40%, depression is the most frequent psychiatric diagnosis in Parkinsons disease. Quality of life in Parkinson's patients is severely restricted. There is still no clear evidence concerning the link between these disorders - findings exist that indicate common neurodegenerative processes. At the same time depression seems to develop as a dysfunctional coping reaction to the motoric, emotional, and social restrictions of Parkinson's disease. The authors point out particular features of the depressive symptom profile in patients with Parkinson's disease and recommend a step-by-step approach to assessing depression: screening, assessment by means of the ICD-10 criteria, quantitative evaluation of depressivity, and assessment of suicidality. A survey of current treatment options is provided: pharmacological, somatic, and psychological approaches are introduced and evaluated with respect to effectiveness in this special group of patients.
引用
收藏
页码:715 / 727
页数:13
相关论文
共 50 条
  • [1] Depression in Parkinson's disease.
    Zesiewicz T.A.
    Hauser R.A.
    [J]. Current Psychiatry Reports, 2002, 4 (1) : 69 - 73
  • [2] Antidepressants in the treatment of hallucinations and comorbid depression in Parkinson's disease.
    Voon, V
    Fox, S
    Lang, AE
    [J]. MOVEMENT DISORDERS, 2004, 19 (09) : 1133 - 1133
  • [3] Treatment complications in Parkinson's disease. How do we manage depression in Parkinson's disease?
    Balaguer-Martinez, Ernest
    [J]. REVISTA DE NEUROLOGIA, 2010, 50 : S45 - S47
  • [4] Depression in Parkinson's disease. The role of pharmacotherapy
    Wierzbinski, Piotr
    Sobow, Tomasz
    [J]. AKTUALNOSCI NEUROLOGICZNE, 2018, 18 (01): : 14 - 20
  • [5] Depression and subsequent risk of Parkinson's disease.
    Van Den Eeden, SK
    Benedict, KS
    Tanner, CM
    Bernstein, A
    Nelson, LM
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S240 - S240
  • [6] Depression as the initial manifestation of Parkinson's disease.
    Anand, KS
    [J]. NEUROLOGY INDIA, 1997, 45 (03) : 202 - 203
  • [7] Treatment of Parkinson's disease. Duodopa®
    Valldeoriola, F.
    [J]. REVISTA DE NEUROLOGIA, 2010, 50 : S34 - S36
  • [8] Combined treatment in Parkinson's disease.
    Reisecker, F
    Ladurner, G
    [J]. NEUROPSYCHIATRIE, 1995, 9 : S27 - S29
  • [9] Levodopa for the Treatment of Parkinson's Disease.
    LeWitt, Peter A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (23): : 2468 - 2476
  • [10] The assessment of depression in Parkinson's disease
    Koerts, J.
    Leenders, K. L.
    Koning, M.
    Bouma, A.
    van Beilen, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (05) : 487 - 492